candesartan has been researched along with tyrosine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukuda, K; Hori, S; Kodama, H; Makino, S; Ogawa, S; Pan, J; Sano, M; Takahashi, T | 1 |
Fujio, Y; Kishimoto, T; Kunisada, K; Matsui, H; Negoro, S; Oh, H; Tone, E; Yamauchi-Takihara, K | 1 |
Akioka, K; Iwao, H; Kim, S; Omura, T; Takeuchi, K; Teragaki, M; Toda, I; Yamagishi, H; Yoshikawa, J; Yoshiyama, M | 1 |
Fujita, T; Goto, A; Onozato, ML; Tojo, A; Wilcox, CS | 1 |
Clark, AJ; Hunyady, L; Karip, E; Süpeki, K; Szidonya, L; Turu, G; Várnai, P | 1 |
Hashimoto, T; Hirawa, N; Imai, N; Ishigami, T; Kihara, M; Kitamura, H; Kiuchi, Y; Nomura, K; Tamura, K; Toya, Y; Umemura, S; Yasuzaki, H; Yoshida, S | 1 |
Funamoto, M; Hasegawa, K; Katanasaka, Y; Miyazaki, Y; Morimoto, T; Sunagawa, Y; Suzuki, H; Wada, H | 1 |
7 other study(ies) available for candesartan and tyrosine
Article | Year |
---|---|
Biphasic activation of the JAK/STAT pathway by angiotensin II in rat cardiomyocytes.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Cells, Cultured; Interferon-gamma; Interferons; Janus Kinase 2; Myocardium; Phosphorylation; Phosphotransferases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Wistar; Signal Transduction; Stereoisomerism; Tetrazoles; Trans-Activators; Tyrosine | 1998 |
Angiotensin II interferes with leukemia inhibitory factor-induced STAT3 activation in cardiac myocytes.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cytoprotection; DNA-Binding Proteins; Dose-Response Relationship, Drug; Growth Inhibitors; Heart Ventricles; Humans; Interleukin-6; Leukemia Inhibitory Factor; Lymphokines; Mice; Myocardium; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT3 Transcription Factor; Tetrazoles; Trans-Activators; Tyrosine | 1998 |
Angiotensin blockade inhibits SIF DNA binding activities via STAT3 after myocardial infarction.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Benzimidazoles; Biphenyl Compounds; DNA-Binding Proteins; Heart Ventricles; Hemodynamics; Imidazoles; Imidazolidines; Male; Myocardial Infarction; Organ Size; Phosphorylation; Rats; Rats, Wistar; Sp1 Transcription Factor; STAT3 Transcription Factor; Tetrazoles; Time Factors; Trans-Activators; Tyrosine | 2000 |
Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetic Nephropathies; Female; Hydrogen Peroxide; Isoquinolines; Kidney; Lipid Peroxidation; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphoproteins; Proteinuria; Quinapril; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Superoxides; Tetrahydroisoquinolines; Tetrazoles; Tyrosine | 2002 |
AT1 receptor blocker-insensitive mutant AT1A angiotensin receptors reveal the presence of G protein-independent signaling in C9 cells.
Topics: Amino Acid Substitution; Angiotensin II Type 1 Receptor Blockers; Animals; Arrestins; Benzimidazoles; beta-Arrestins; Biphenyl Compounds; Cells, Cultured; Chlorocebus aethiops; COS Cells; Epithelial Cells; GTP-Binding Proteins; Muscles; Mutation; Rats; Receptor, Angiotensin, Type 1; Serine; Signal Transduction; Tetrazoles; Tyrosine | 2007 |
Urinary oxidative stress markers closely reflect the efficacy of candesartan treatment for diabetic nephropathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Deoxyguanosine; Diabetes Mellitus; Diabetic Nephropathies; Dinoprost; Disease Models, Animal; Hydralazine; Kidney Glomerulus; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Tetrazoles; Treatment Outcome; Tyrosine | 2009 |
Tyrosine phosphorylation of RACK1 triggers cardiomyocyte hypertrophy by regulating the interaction between p300 and GATA4.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Cell Enlargement; Cells, Cultured; Disease Models, Animal; E1A-Associated p300 Protein; GATA4 Transcription Factor; Gene Knockdown Techniques; HEK293 Cells; Humans; Male; Myocytes, Cardiac; Neoplasm Proteins; Phenylephrine; Phosphorylation; Protein Binding; Rats; Rats, Inbred Dahl; Receptors for Activated C Kinase; Tetrazoles; Transcription, Genetic; Tyrosine | 2016 |